[[ type === 'moc' ? 'MARKET ON CLOSE' : 'FREE WEBINAR' ]]
[[ timeLabel ]] WATCH LIVE:
Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Join Barchart Premier to get Screeners that run automatically with the results emailed to you! FREE 30 Day Trial
Stocks | Futures | Watchlist | News | More
or
Faster, Cleaner, Better.

Sionna Therapeutics Inc (SION)

Sionna Therapeutics Inc (SION)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]] ([[ financialData.relativeStrengthDirection14d ]]) ([[ financialData.highPercent1y ]]) ([[ financialData.lowPercent1y ]])
Realtime quote and/or trades are not sourced from all markets.

Fundamentals

See More
  • Market Capitalization, $K 1,857,020
  • Shares Outstanding, K 45,150
  • Annual Sales, $ 0 K
  • Annual Income, $ -75,270 K
  • EBIT $ -99 M
  • EBITDA $ -101 M
  • 60-Month Beta 1.35
  • Price/Sales N/A
  • Price/Cash Flow N/A
  • Price/Book 6.44

Options Overview Details

View History
  • Implied Volatility 100.41% (+5.53%)
  • Historical Volatility 71.81%
  • IV Percentile 67%
  • IV Rank 74.39%
  • IV High 109.32% on 03/20/26
  • IV Low 74.54% on 03/18/26
  • Expected Move (DTE 23) 8.64 (20.14%)
  • Put/Call Vol Ratio 0.00
  • Today's Volume 13
  • Volume Avg (30-Day) 60
  • Put/Call OI Ratio 2.95
  • Today's Open Interest 1,781
  • Open Int (30-Day) 1,499
  • Expected Range 34.24 to 51.52

Analyst Rating / Earnings Estimates

Current Rating
See More
Moderate Buy
Based on 12 analysts offering recommendations.
Earnings Estimates - Current Qtr 06/30/26
See More
  • Average Estimate $-0.65
  • Number of Estimates 4
  • High Estimate $-0.61
  • Low Estimate $-0.70
  • Prior Year $-0.41
  • Growth Rate Est. (year over year) -58.54%

Price Performance

See More
Period Period Low Period High Performance
1-Month
36.50 +17.48%
on 04/29/26
48.44 -11.49%
on 05/11/26
+4.77 (+12.52%)
since 04/24/26
3-Month
32.56 +31.68%
on 03/02/26
48.44 -11.49%
on 05/11/26
+4.88 (+12.84%)
since 02/26/26
52-Week
12.52 +242.36%
on 05/27/25
48.44 -11.49%
on 05/11/26
+30.16 (+237.11%)
since 05/23/25

Most Recent Stories

More News
Sionna Therapeutics to Participate in the 2026 RBC Capital Markets Global Healthcare Conference

WALTHAM, Mass., May 13, 2026 (GLOBE NEWSWIRE) -- Sionna Therapeutics, Inc. (Nasdaq: SION), a clinical-stage biopharmaceutical company on a mission to revolutionize the current treatment paradigm for...

SION : 42.88 (+4.25%)
Sionna Therapeutics Reports First Quarter 2026 Financial Results

Enrollment completed in the PreciSION CF Phase 2a proof-of-concept trial evaluating NBD1 stabilizer SION-719 as an add-on to standard of care in participants with cystic fibrosis; topline data on track...

SION : 42.88 (+4.25%)
Sionna Therapeutics Completes Enrollment in PreciSION CF Phase 2a Trial Evaluating NBD1 Stabilizer, SION-719, Added to Standard of Care in Participants with Cystic Fibrosis

WALTHAM, Mass., April 27, 2026 (GLOBE NEWSWIRE) -- Sionna Therapeutics, Inc. (Nasdaq: SION), a clinical-stage biopharmaceutical company on a mission to revolutionize the current treatment paradigm for...

SION : 42.88 (+4.25%)
Sionna Therapeutics to Participate in the Raymond James 2026 Biotech Innovation Symposium

WALTHAM, Mass., April 07, 2026 (GLOBE NEWSWIRE) -- Sionna Therapeutics, Inc. (Nasdaq: SION), a clinical-stage biopharmaceutical company on a mission to revolutionize the current treatment paradigm for...

SION : 42.88 (+4.25%)
Sionna Therapeutics Reports Fourth Quarter and Full Year 2025 Financial Results

Ongoing PreciSION CF Phase 2a proof-of-concept trial evaluating NBD1 stabilizer SION-719 as an add-on to standard of care in participants with cystic fibrosis is on track with topline data anticipated...

SION : 42.88 (+4.25%)
Sionna Therapeutics to Participate in Upcoming March 2026 Investor Conferences

WALTHAM, Mass., Feb. 23, 2026 (GLOBE NEWSWIRE) -- Sionna Therapeutics, Inc. (Nasdaq: SION), a clinical-stage biopharmaceutical company on a mission to revolutionize the current treatment paradigm for...

SION : 42.88 (+4.25%)
Sionna Therapeutics to Present at the Guggenheim Securities Emerging Outlook: Biotech Summit 2026

WALTHAM, Mass., Feb. 04, 2026 (GLOBE NEWSWIRE) -- Sionna Therapeutics, Inc. (Nasdaq: SION), a clinical-stage biopharmaceutical company on a mission to revolutionize the current treatment paradigm for...

SION : 42.88 (+4.25%)
Sionna Therapeutics to Present at the 44th Annual J.P. Morgan Healthcare Conference

WALTHAM, Mass., Jan. 05, 2026 (GLOBE NEWSWIRE) -- Sionna Therapeutics, Inc. (Nasdaq: SION), a clinical-stage biopharmaceutical company on a mission to revolutionize the current treatment paradigm for...

SION : 42.88 (+4.25%)
Stocks Retreat as Bond Yields Rise

The S&P 500 Index ($SPX ) (SPY ) on Monday closed down by -0.53%, the Dow Jones Industrials Index ($DOWI ) (DIA ) closed down by -0.90%, and the Nasdaq 100 Index ($IUXX ) (QQQ ) closed down by -0.36%....

MSTR : 159.93 (+0.03%)
MPC : 248.05 (-2.59%)
GLXY : 29.62 (+3.39%)
LVS : 49.75 (+0.65%)
WYNN : 97.87 (+0.65%)
$IUXX : 30,001.32 (+1.76%)
COIN : 180.01 (-2.69%)
ZNM26 : 109-295 (+0.09%)
SHOP : 104.90 (+1.84%)
SION : 42.88 (+4.25%)
ESM26 : 7,533.25 (-0.05%)
FANG : 195.13 (-2.78%)
Stocks Fall as Rising Bond Yields Spark Risk-Off Sentiment

The S&P 500 Index ($SPX ) (SPY ) today is down by -0.28%, the Dow Jones Industrials Index ($DOWI ) (DIA ) is down by -0.48%, and the Nasdaq 100 Index ($IUXX ) (QQQ ) is down by -0.29%. December E-mini...

MSTR : 159.93 (+0.03%)
MPC : 248.05 (-2.59%)
CVX : 184.71 (-3.51%)
GLXY : 29.62 (+3.39%)
LVS : 49.75 (+0.65%)
WYNN : 97.87 (+0.65%)
$IUXX : 30,001.32 (+1.76%)
COIN : 180.01 (-2.69%)
ZNM26 : 109-295 (+0.09%)
SHOP : 104.90 (+1.84%)
OXY : 57.46 (-2.30%)
SION : 42.88 (+4.25%)

Barchart Technical Opinion

The Barchart Technical Opinion rating is a 96% Buy with a Strongest short term outlook on maintaining the current direction.

Long term indicators fully support a continuation of the trend.

See More Share

Business Summary

Sionna Therapeutics Inc. is a clinical-stage biopharmaceutical company by developing novel medicines that normalize the function of the CFTR protein. Sionna Therapeutics Inc. is based in BOSTON.

See More

Key Turning Points

3rd Resistance Point 46.47
2nd Resistance Point 44.81
1st Resistance Point 43.85
Last Price 42.88
1st Support Level 41.22
2nd Support Level 39.56
3rd Support Level 38.60

See More

52-Week High 48.44
Last Price 42.88
Fibonacci 61.8% 34.72
Fibonacci 50% 30.49
Fibonacci 38.2% 26.25
52-Week Low 12.52

See More

Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.